| Home - Site Map - This Site Is For Sale | ||
|
Gadolinium MRI Side Effects | |
|
 |
 |
Have You Been Exposed?
NSF may develop in people with kidney disease who undergo magnetic resonance imaging or magnetic resonance angiography. Gadolinium is used in some MRI and MRA contrast agents. NSF causes skin to thicken so that people can't bend or extend joints. NSF also can develop in thigh muscles, lung vessels, the diaphragm and lower abdomen. Over time, it can lead to death. This website provides nonmedical information about the disease to help you avoid exposure. Following links on this site also may provide guidance on what to do after you have been exposed. If you have received an MRI or MRA and experience any of the symptoms discussed in these pages, you should contact your doctor immediately. If you believe you have been harmed by gadolinium exposure, it may be wise to seek legal counsel.
Additional Resources about Gadolinium Side Effects
What is Gadolinium?
Gadolinium Side Effects View videos about gadolinium and gadolinium side effects
Gadolinium Side Effects Videos
Gadolinium - Periodic Table of VideosJan 20, 2012 Gadolinium is element number 64. Videos about all the elements at www.periodicvideos.com 
What Is GadoliniumOct 24, 2011 Name Origin Named after the Finnish chemist and geologist Johan Gadolin. "Gadolinium" in different languages. Sources Gadolinium is never found in nature in elemental form. It is obtained from many rare minerals such as bastnasite, monazite and trace amounts in gadolinite. Primary mining deposits are located in the USA, Brazil, India, Sri Lanka, Australia and China. Annual production is around 400tons. Abundance Universe: 0.002 ppm (by weight) Sun: 0.002 ppm (by weight) Carbonaceous meteorite: 0.23 ppm Earth's Crust: 7.7 ppm Seawater: Atlantic surface: 5.2 x 10-7 ppm Atlantic deep: 9.3 x 10-7 ppm Pacific surface: 6 x 10-7 ppm Pacific deep: 1.5 x 10-6 ppm Uses Compounds of gadolinium are used in making phosphors for colour TV tubes and in the manufacture of compact discs and computer memory. Gallium Gadolinium Garnet (Gd3Ga5O12) is a material with good optical properties, and is used in fabrication of various optical components and as substrate material for magneto-optical films. Gadolinium is used for making gadolinium yttrium garnets, which have microwave applications. Solutions of organic gadolinium complexes are used as intravenous radiocontrast agents to enhance images in medical magnetic resonance imaging. Because of their paramagnetic properties, gadolinium compounds are used in magnetic resonance imaging (MRI). History In 1880, Swiss chemist Jean Charles Galissard de Marignac observed spectroscopic lines due to gadolinium in samples of didymium and gadolinite ... 
Papantonio - Gadolinium: the General Electric Cover Up - PT. 1/2Sep 22, 2011 When GE Healthcare came out with a new MRI contrast dye almost two decades ago, they told doctors that their new product would allow them to get clearer pictures of patients and make diagnosing brain tumors or other abnormalities easier than ever. What they didn't tell these doctors was that their own lab tests showed that the main component of this dye, called Gadolinium, was causing irreversible diseases in lab rats. And once these effects were seen in human patients, the company continued to deny that their contrast dye was to blame. Mike Papantonio talks with attorney Troy Rafferty, who is handling some of the cases against GE Healthcare. 
FDA MRI Contrast Gadolinium WarningsOct 12, 2011 YouHaveALawyer.com: A segment from the FDA Patient Safety News about new warnings for gadolinium based MRI contrast agents due to a risk of nephrogenic systemic fibroris (NSF). More information available at www.fda.gov or www.youhavealawyer.com/gadolinium 
Caution on Gadolinium-Containing Contrast Agents (Aug. 2006)Aug 25, 2010 FDA has learned of a rare, possibly fatal disease among patients with renal failure who underwent Magnetic Resonance Angiography (MRA) using Omniscan, a contrast agent containing gadolinium. The disease is called Nephrogenic Systemic Fibrosis/ Nephrogenic Fibrosing Dermopathy (NSF/NFD). To date, NSF/NFD has been found almost exclusively in patients with renal failure. The disease is characterized by fibrosis of the skin and connective tissues. Five gadolinium-containing contrast agents have been approved in the US for use with MRI. However, none have been approved for MRA, where the doses are up to three times higher than for MRI. But these agents have been used off-label for MRA. At this point a causal relationship between gadolinium-containing contrast agents and NSF/NFD has not been established. FDA is investigating the reports received so far, other data bases and the medical literature to try to answer this question. In the meantime, FDA says that physicians should be cautious about using gadolinium-containing contrast agents in patients with advanced renal failure. Although there are no data to determine the utility of dialysis to prevent or treat NSF/NSD in patients with decreased kidney function, there is evidence that dialysis can accelerate the excretion of gadolinium. So it may be prudent to institute prompt dialysis in patients with advanced kidney dysfunction who receive a gadolinium contrast MRA. Patients should be aware of the signs and symptoms and report ... 
Update on Avoiding Gadolinium-Containing Contrast Agents inDec 23, 2011 FDA has received reports of 65 more cases of a rare, possibly fatal disease in patients with renal failure who receive a contrast agent containing gadolinium while undergoing certain imaging procedures. The disease, called Nephrogenic Systemic Fibrosis/Nephrogenic Fibrosing Dermopathy (NSF/NFD), is characterized by fibrosis of the skin and internal organs. These new reports are in addition to cases that were reported on in mid-2006. In the new reports, the affected patients had end-stage kidney failure, and had either Magnetic Resonance Angiography (MRA) or Magnetic Resonance Imaging (MRI) with a gadolinium-based contrast agent. Their NSF/NFD began from 2 days to 18 months after exposure to the contrast agent. Although many of these patients received large amounts of the contrast agent, some received only one dose. In addition, researchers have found gadolinium deposits in the skin of patients who developed NSF/NFD. There are currently five FDA-approved gadolinium-based contrast agents. Magnevist, MultiHance, Omniscan, OptiMARK, and ProHance. These agents are approved for use during an MRI scan, but not for MRA. Although NSF/NFD has been reported for only 3 of these 5 agents, FDA believes that there is a potential for NSF/NFD to occur with the use of any of the approved gadolinium-based agents. Because of this, FDA is recommending that whenever possible, health care professionals choose imaging methods other than MRI or MRA with gadolinium for patients with moderate to ... 
GadoliniumSep 06, 2011 Medical Animations by High Impact Graphics. Learn more at HighImpact.com or give us a call at 800-749-2184. 
Chemistry & Biology : How Many Neutrons Does Gadolinium Have?Nov 23, 2011 Gadolinium has 93 neutrons, and this number is figured by using the equation which states that neutrons plus protons equal the atomic mass. Use chemistry equations to determine the amount of neutrons that an element has withhelp from a science teacher and field biologist in this free video on chemistry. Expert: Brian Erickson Contact: Ericksontutoring.blogspot.com Bio: Brian Erickson is a tutor in math and science, as well as a field biologist. Filmmaker: Todd Green 
Gadolinium MRI Contrast Dye Litigation - Howard NationsApr 03, 2011 Attorney Howard L. Nations explains the deadly effects of Gadolinium MRI contrast dyes. Visit: www.contrastdye-lawsuit.com for more information and a free case evaluation. 
Papantonio - Gadolinium: the General Electric Cover Up - PT. 2/2Sep 22, 2011 When GE Healthcare came out with a new MRI contrast dye almost two decades ago, they told doctors that their new product would allow them to get clearer pictures of patients and make diagnosing brain tumors or other abnormalities easier than ever. What they didn't tell these doctors was that their own lab tests showed that the main component of this dye, called Gadolinium, was causing irreversible diseases in lab rats. And once these effects were seen in human patients, the company continued to deny that their contrast dye was to blame. Mike Papantonio talks with attorney Troy Rafferty, who is handling some of the cases against GE Healthcare. 
Kidney Function in Filtering Contrast (Gadolinium) Medical AnimationJan 17, 2012 www.medivisuals.com - Please visit our website at http 
Gadolinium, Toxic Element Used in MRIs: The FDA Fails Aga...Oct 21, 2011 www.levinlaw.com Gadolinium, a toxic element used in MRIs, can cause the disease nephrogenic systemic fibrosis in people with kidney problems. The FDA was slow to act, and the US Chamber of Commerce wants to limit victim's rights to sue. 
Kidney Disease Information - What You Need To Know
Kidney Disease in Dogs
Want to know about Medical Malpractice?
|
|
Home | Site Map | This Site Is For Sale | |
Gadolinium has been the focus of many lawsuits recently because it has been linked to a potentially life threatening condition known as nephrogenic systemic fibrosis (NSF).
